<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761172</url>
  </required_header>
  <id_info>
    <org_study_id>NL67828.058.18</org_study_id>
    <nct_id>NCT04761172</nct_id>
  </id_info>
  <brief_title>NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours</brief_title>
  <official_title>Near-infrared Fluorescence Imaging With IndoCyanine Green for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label pilot study including 10 GIST patients scheduled for an elective open&#xD;
      or laparoscopic resection at Leiden University Medical Center (LUMC) and Erasmus Medical&#xD;
      Center (EMC), Rotterdam. Patients will receive a single dose injection of 10mg ICG at a given&#xD;
      moment during the 24 hours prior to surgery or during surgery. The timing of administration&#xD;
      will be determined according to a step-up, step-down procedure. Standard of care surgery will&#xD;
      be performed and a NIR fluorescence imaging system will be used to record the GIST under&#xD;
      fluorescence.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open-label pilot study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary tumor detection</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Tumor detection perceived by the surgeon with and without NIR-imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of peritoneal tumor depositions</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Detection of peritoneal tumor depositions by the surgeon with and without NIR-imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor to background ratio</measure>
    <time_frame>Through study completion, estimated to be 6 months</time_frame>
    <description>Pixel intensity ratio on static images</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>GIST</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative near-infrared fluorescence imaging using indocyaninegreen</intervention_name>
    <description>ICG administration before/during surgery and using near-infrared fluorescence imaging for intra-operative detection and identification of GISTs</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with GIST by histology or cytology, localized or metastasized,&#xD;
             scheduled to undergo an elective open or laparoscopic resection.&#xD;
&#xD;
          -  18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of an allergy or hypersensitivity to sodium iodide, iodine or ICG&#xD;
&#xD;
          -  Patients with hyperthyroidism and patients with an autonomous thyroid adenoma&#xD;
&#xD;
          -  Patients pregnant or breastfeeding&#xD;
&#xD;
          -  Patients with severe renal insufficiency (eGFR &lt;30)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. A. van der Hage</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>G. M. Kalisvaart, MD</last_name>
    <phone>0715263695</phone>
    <email>g.m.kalisvaart@lumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G. M. Kalisvaart</last_name>
      <email>g.m.kalisvaart@lumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H. A. Galema</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>javanderhage</investigator_full_name>
    <investigator_title>Prof. dr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>On request anonymized data can be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

